International Trial for C. diff Vaccine to Be Held in 17 Countries

An investigational vaccine for the prevention of Clostridium difficile infections will undergo an international Phase III trial, according to a Gastroenterology Update.

The placebo-controlled, randomized trial will include 15,000 adults in 17 countries. Volunteers for the trial are currently being recruited in Australia.

The vaccine, developed by Sanofi Pasteur, is designed to protect at-risk individuals from C. diff infections.

More Articles on Gastroenterology:
Drs. Richard Fedorak, Haili Wang Develop Urine Test for Detection of Colonic Polyps
Study: Thalidomide as Treatment for Pediatric Crohn's Disease
6 Statistics on GI/Endoscopy Revenue Per Case in Surgery Centers by Number of ORs

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers

Featured Podcast